Tower Research Capital (TRC)’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.4K | Sell |
|
|||||
|
2025
Q2 | $54.8K | Buy |
|
|||||
|
2025
Q1 | $22.6K | Sell |
|
|||||
|
2024
Q4 | $35.8K | Buy |
|
|||||
|
2024
Q3 | $79.3K | Sell |
|
|||||
|
2024
Q2 | $59.9K | Buy |
|
|||||
|
2024
Q1 | $6.16K | Sell |
|
|||||
|
2023
Q4 | $90K | Buy |
|
|||||
|
2023
Q3 | $96.6K | Buy |
|
|||||
|
2023
Q2 | $6.83K | Sell |
|
|||||
|
2023
Q1 | $12K | Buy |
|
|||||
|
2022
Q4 | $5K | Sell |
|
|||||
|
2022
Q3 | $49K | Sell |
|
|||||
|
2022
Q2 | $45K | Buy |
|
|||||
|
2022
Q1 | $51K | Buy |
|
|||||
|
2021
Q4 | $8K | Sell |
|
|||||
|
2021
Q3 | $19K | Sell |
|
|||||
|
2021
Q2 | $130K | Buy |
|
|||||
|
2021
Q1 | $49K | Sell |
|
|||||
|
2020
Q4 | $72K | Sell |
|
|||||
|
2020
Q3 | $411K | Buy |
|
|||||
|
2020
Q2 | $71K | Buy |
|